Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maddy Dorr

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Urology|June 27, 2024
End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney DiseaseAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
The Journal of Urology|July 30, 2024
Reply by AuthorsAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
The Journal of Urology|August 26, 2025
Growth Kinetics of Venous Tumor Thrombus from Renal Cell CarcinomaMatthew T McLeay, Daniel S Roberson, Maddy Dorr, et al.
Nature Communications|March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trialJacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Urology|June 27, 2024
End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney DiseaseAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
The Journal of Urology|July 30, 2024
Reply by AuthorsAbhinav Khanna, Harrison C Gottlich, Maddy Dorr, et al.
The Journal of Urology|August 26, 2025
Growth Kinetics of Venous Tumor Thrombus from Renal Cell CarcinomaMatthew T McLeay, Daniel S Roberson, Maddy Dorr, et al.
Nature Communications|March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trialJacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
Pageof 1